title: Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.
abstract: The small extracellular matrix proteoglycan decorin which possesses a potent antitumor activity has been shown to be present in various amounts in the stroma of several tumors including those of the breast. Regarding decorin in breast malignancies the published data are conflicting, i.e., whether breast cancer cells express it or not. Here, we first compared decorin gene expression levels between healthy human breast tissue and selected types of human breast cancer using GeneSapiens databank. Next, we localized decorin mRNA in tissue specimen of normal human breast, intraductal breast papillomas and various histologic types of human breast cancer using in situ hybridization (ISH) with digoxigenin-labeled RNA probes for decorin. We also examined the effect of decorin transduction on the behavior of cultured human breast cancer MCF7 cells. Analysis of GeneSapiens databank revealed that in various human breast cancers decorin expression is significant. However, ISH results clearly demonstrated that human breast cancer cells independently of the type of the cancer do not express decorin mRNA. This was also true for papilloma-forming cells of the human breast. Indeed, decorin gene expression in healthy human breast tissue as well as in benign and malignant tumors of human breast was shown to take place solely in cells of the original stroma. Decorin transduction using decorin adenoviral vector in decorin-negative MCF7 cells resulted in a significant decrease in the proliferation of these cells and changed cell cohesion. Decorin-transduced MCF7 cells also exhibited increased apoptosis. In conclusion, our study shows that in human breast tissue only cells of the original stroma are capable of decorin gene expression. Our study also shows that transduction of decorin in decorin-negative human breast cancer cells markedly modulates the growth pattern of these cells.
authors.affiliation: Department of Pathology, Turku University Hospital, University of Turku, Kiinamyllynkatu 4-8, 20520 Turku, Finland. pia.bostrom@tyks.fi
authors.forename: Pia
authors.initials: P
authors.lastname: Boström
authors.forename: Annele
authors.initials: A
authors.lastname: Sainio
authors.forename: Tanja
authors.initials: T
authors.lastname: Kakko
authors.forename: Mikko
authors.initials: M
authors.lastname: Savontaus
authors.forename: Mirva
authors.initials: M
authors.lastname: Söderström
authors.forename: Hannu
authors.initials: H
authors.lastname: Järveläinen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002448:Cell Adhesion; D049109:Cell Proliferation; D058575:Decorin / Q000235:genetics / Q000378:metabolism*; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D017403:In Situ Hybridization; D061986:MCF-7 Cells; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism; D017154:Stromal Cells / Q000378:metabolism / Q000473:pathology; D014161:Transduction, Genetic; D014162:Transfection
chemical_list: C546878:DCN protein, human; D058575:Decorin; D012333:RNA, Messenger